New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator safety and immunogenicity trial in…
Potential game-changer Indian vaccine for COVID-19
New Delhi: A new chapter in the fight against the ongoing epidemic of COVID-19 has begun with the Drug Controller General of India (DCGI) giving…